Ypsomed
Ypsomed Holding AG, commonly known as Ypsomed, is a leading Swiss company headquartered in Burgdorf, Switzerland (CH). Founded in 1984, Ypsomed has established itself as a key player in the medical technology industry, specialising in the development and manufacturing of innovative drug delivery systems and diabetes management solutions. With a strong presence in Europe and expanding operations in Asia and North America, Ypsomed is renowned for its cutting-edge products, including insulin delivery devices and pen systems. The company’s commitment to quality and user-centric design sets it apart in a competitive market. Ypsomed has achieved significant milestones, including partnerships with major pharmaceutical companies, solidifying its position as a trusted provider in the healthcare sector.
DitchCarbon Score
How does Ypsomed's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ypsomed's score of 78 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ypsomed's reported carbon emissions
In 2023, Ypsomed AG reported total greenhouse gas emissions of approximately 116,156,000 kg CO2e, with 2,256,000 kg CO2e from Scope 1, 29,000 kg CO2e from Scope 2, and a significant 113,871,000 kg CO2e from Scope 3 emissions. This reflects a continued commitment to reducing their carbon footprint across all scopes. Ypsomed has set ambitious targets to achieve substantial reductions in greenhouse gas emissions. The company aims to reduce absolute Scope 1 and 2 emissions by 32% by 2027, using 2020 as the base year. Furthermore, they have committed to a remarkable 90% reduction in these emissions by 2030. For Scope 3 emissions, Ypsomed targets a 52% reduction per unit of million CHF value added by 2030 and a 97% reduction per million CHF of value added by 2040. Additionally, Ypsomed has pledged to reach net-zero greenhouse gas emissions across its entire value chain by 2040, starting from the 2020 baseline. This comprehensive approach underscores Ypsomed's dedication to sustainability and climate action, aligning with industry standards for reducing greenhouse gas emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | - | 00,000 | - | 0,000 | 00,000 | - |
| Scope 3 | - | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ypsomed is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
